Populationen inkluderede 27, 8% kvinder, 58, 4% patienter ≥ 60 år (26% ≥ 70 år) og 54, 5% patienter der fik fibrinolytika.
The population included 27.8% women, 58.4% patients ≥ 60 years (26% ≥ 70 years) and 54.5% patients who received fibrinolytics.